The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments

Journal of Pain and Symptom Management

Volumn 53, Issue 3, 2017, Pages 630-643

  Hui, David ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Clinical trial; dyspnea; fatigue; neoplasms; pain; palliative care; personalized medicine; surveys and questionnaires; symptom assessment

Indexed keywords

CANCER PALLIATIVE THERAPY; DISEASE CONTROL; EDMONTON SYMPTOM ASSESSMENT SYSTEM; ELECTRONIC HEALTH RECORD; ELECTRONIC MEDICAL RECORD; HUMAN; MALIGNANT NEOPLASM; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; OUTPATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING; STANDARDIZATION; SYMPTOM ASSESSMENT; VALIDATION PROCESS; SEVERITY OF ILLNESS INDEX;

HUMANS; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT;

EID: 85011965270     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2016.10.370     Document Type: Review

References (130)

1. 1 Solano, J.P., Gomes, B., Higginson, I.J., A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 31 (2006), 58–69.
2. 2 Teunissen, S.C., Wesker, W., Kruitwagen, C., de Haes, H.C., Voest, E.E., de Graeff, A., Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34 (2007), 94–104.
3. 3 Portenoy, R.K., Thaler, H.T., Kornblith, A.B., et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3 (1994), 183–189.
4. 4 Chang, V.T., Hwang, S.S., Feuerman, M., Kasimis, B.S., Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 88 (2000), 1175–1183.
5. 5 Walsh, D., Donnelly, S., Rybicki, L., The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8 (2000), 175–179.
6. 6 Dionne-Odom, J.N., Hull, J.G., Martin, M.Y., et al. Associations between advanced cancer patients' survival and family caregiver presence and burden. Cancer Med 5 (2016), 853–862.
7. 7 Bruera, E., Hui, D., Palliative care research: lessons learned by our team over the last 25 years. Palliat Med 27 (2013), 939–951.
8. 8 Hui, D., Bruera, E., A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol 32 (2014), 1640–1646.
9. 9 Hui, D., Bruera, E., Supportive and palliative oncology: a new paradigm for comprehensive cancer care. Hematol Oncol Rev 9 (2013), 68–74.
10. 10 Bruera, E., Kuehn, N., Miller, M.J., Selmser, P., Macmillan, K., The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7 (1991), 6–9.
11. 11 Bruera, E., MacDonald, S., Audit methods: the Edmonton Symptom Assessment System. Higginson, I., (eds.) Clinical Audit in Palliative Care, 1993, Radcliffe Medical Press, Oxford, 61–77.
12. 12 Philip, J., Smith, W.B., Craft, P., Lickiss, N., Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer 6 (1998), 539–541.
13. 13 Chang, V.T., Hwang, S.S., Feuerman, M., Validation of the Edmonton Symptom Assessment Scale. Cancer 88 (2000), 2164–2171.
14. 14 Nekolaichuk, C., Watanabe, S., Beaumont, C., The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991–2006). Palliat Med 22 (2008), 111–122.
15. 15 Richardson, L.A., Jones, G.W., A review of the reliability and validity of the Edmonton Symptom Assessment System. Curr Oncol, 16, 2009, 55.
16. 16 Zeng, L., Zhang, L., Culleton, S., et al. Edmonton symptom assessment scale as a prognosticative indicator in patients with advanced cancer. J Palliat Med 14 (2011), 337–342.
17. 17 Mercadante, S., Valle, A., Porzio, G., Aielli, F., Adile, C., Casuccio, A., Prognostic factors of survival in patients with advanced cancer admitted to home care. J Pain Symptom Manage 45 (2013), 56–62.
18. 18 Barbera, L., Atzema, C., Sutradhar, R., et al. Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. Ann Emerg Med 61 (2013), 427–437.e425.
19. 19 Hjermstad, M.J., Fayers, P.M., Haugen, D.F., et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 41 (2011), 1073–1093.
20. 20 Hannon, B., Dyck, M., Pope, A., et al. Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer. J Pain Symptom Manage 49 (2015), 945–952.
21. 21 Delgado-Guay, M.O., Chisholm, G., Williams, J., Frisbee-Hume, S., Ferguson, A.O., Bruera, E., Frequency, intensity, and correlates of spiritual pain in advanced cancer patients assessed in a supportive/palliative care clinic. Palliat Support Care 14 (2016), 341–348.
22. 22 Delgado-Guay, M., Ferrer, J., Rieber, A.G., et al. Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist 20 (2015), 1092–1098.
23. 23 Garyali, A., Palmer, J.L., Yennurajalingam, S., Zhang, T., Pace, E.A., Bruera, E., Errors in symptom intensity self-assessment by patients receiving outpatient palliative care. J Palliat Med 9 (2006), 1059–1065.
24. 24 Watanabe, S., Nekolaichuk, C., Beaumont, C., Mawani, A., The Edmonton symptom assessment system–what do patients think?. Support Care Cancer 17 (2009), 675–683.
25. 25 Watanabe, S.M., Nekolaichuk, C., Beaumont, C., Johnson, L., Myers, J., Strasser, F., A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manage 41 (2011), 456–468.
26. 26 Claessens, P., Menten, J., Schotsmans, P., Broeckaert, B., Development and validation of a modified version of the Edmonton Symptom Assessment Scale in a Flemish palliative care population. Am J Hosp Palliat Care 28 (2011), 475–482.
27. 27 Paiva, C.E., Manfredini, L.L., Paiva, B.S., Hui, D., Bruera, E., The Brazilian version of the Edmonton Symptom Assessment System (ESAS) is a feasible, valid and reliable instrument for the measurement of symptoms in advanced cancer patients. PLoS One, 10, 2015, e0132073.
28. 28 Dong, Y., Chen, H., Zheng, Y., et al. Psychometric validation of the Edmonton Symptom Assessment System in Chinese patients. J Pain Symptom Manage 50 (2015), 712–717.e712.
29. 29 Pautex, S., Berger, A., Chatelain, C., Herrmann, F., Zulian, G.B., Symptom assessment in elderly cancer patients receiving palliative care. Crit Rev Oncol Hematol 47 (2003), 281–286.
30. 30 Stiel, S., Matthes, M.E., Bertram, L., Ostgathe, C., Elsner, F., Radbruch, L., (Trans.) Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative care: the German version of the Edmonton Symptom Assessment Scale (ESAS) Schmerz (Berlin, Germany) 24 (2010), 596–604.
31. 31 Gretarsdottir, H., Fridriksdottir, N., Gunnarsdottir, S., Psychometric properties of the Icelandic version of the revised Edmonton Symptom Assessment Scale. J Pain Symptom Manage 51 (2016), 133–137.
32. 32 Moro, C., Brunelli, C., Miccinesi, G., et al. Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14 (2006), 30–37.
33. 33 Yokomichi, N., Morita, T., Nitto, A., et al. Validation of the Japanese version of the Edmonton Symptom Assessment System-revised. J Pain Symptom Manage 50 (2015), 718–723.
34. 34 Kwon, J.H., Nam, S.H., Koh, S., et al. Validation of the Edmonton Symptom Assessment System in Korean patients with cancer. J Pain Symptom Manage 46 (2013), 947–956.
35. 35 Al-Shahri, M.Z., Al-Zahrani, A.S., Alansari, A., et al. Validation of an Arabic Questionnaire for Symptom Assessment. Am J Hosp Palliat Care, 2016 (in press).
36. 36 Carvajal, A., Centeno, C., Watson, R., Bruera, E., A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer 47 (2011), 1863–1872.
37. 37 Chinda, M., Jaturapatporn, D., Kirshen, A.J., Udomsubpayakul, U., Reliability and validity of a Thai version of the Edmonton Symptom Assessment Scale (ESAS-Thai). J Pain Symptom Manage 42 (2011), 954–960.
38. 38 Yeşilbalkan, Ö.U., Özkütük, N., Karadakovan, A., Turgut, T., Kazgan, B., Validity and reliability of the Edmonton Symptom Assessment Scale in Turkish cancer patients. Turk J Cancer 38 (2008), 62–67.
39. 39 Selby, D., Cascella, A., Gardiner, K., et al. A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manage 39 (2010), 241–249.
40. 40 Oldenmenger, W.H., de Raaf, P.J., de Klerk, C., van der Rijt, C.C., Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review. J Pain Symptom Manage 45 (2013), 1083–1093.
41. 41 Yamaguchi, T., Morita, T., Nitto, A., et al. Establishing cutoff points for defining symptom severity using the Edmonton Symptom Assessment System-revised Japanese version. J Pain Symptom Manage 51 (2016), 292–297.
42. 42 Seow, H., Sussman, J., Martelli-Reid, L., Pond, G., Bainbridge, D., Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract/Am Soc Clin Oncol 8 (2012), e142–e148.
43. 43 Hui, D., Park, M., Shamieh, O., et al. Personalized symptom goals and response in patients with advanced cancer. Cancer 22 (2016), 1774–1781.
44. 44 Hui, D., Shamieh, O., Paiva, C., et al. Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: a prospective study. Cancer 121 (2015), 3027–3035.
45. 45 Hui, D., Shamieh, O., Paiva, C.E., et al. Minimal clinically important difference in the physical, emotional, and total symptom distress scores of the Edmonton Symptom Assessment System. J Pain Symptom Manage 51 (2016), 262–269.
46. 46 Bedard, G., Zeng, L., Zhang, L., et al. Minimal clinically important differences in the Edmonton Symptom Assessment System in patients with advanced cancer. J Pain Symptom Manage, 2012.
47. 47 Hui, D., Bruera, E., Minimal clinically important differences in the Edmonton Symptom Assessment System: the anchor is key. J Pain Symptom Manage 45 (2013), e4–e5.
48. 48 Zimmermann, C., Burman, D., Bandukwala, S., et al. Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients. Support Care Cancer 18 (2010), 609–616.
49. 49 Yennurajalingam, S., Kwon, J.H., Urbauer, D.L., Hui, D., Reyes-Gibby, C.C., Bruera, E., Consistency of symptom clusters among advanced cancer patients seen at an outpatient supportive care clinic in a tertiary cancer center. Palliat Support Care 11 (2013), 473–480.
50. 50 Cheung, W.Y., Le, L.W., Zimmermann, C., Symptom clusters in patients with advanced cancers. Support Care Cancer 17 (2009), 1223–1230.
51. 51 Cheung, W.Y., Barmala, N., Zarinehbaf, S., Rodin, G., Le, L.W., Zimmermann, C., The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manage 37 (2009), 297–304.
52. 52 Yennurajalingam, S., Urbauer, D.L., Casper, K.L., et al. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage 41 (2010), 49–56.
53. 53 Hui, D., Dos Santos, R., Chisholm, G., Bruera, E., Symptom expression in the last 7 days of life among cancer patients admitted to acute palliative care units. J Pain Symptom Manage 50 (2015), 488–494.
54. 54 Modonesi, C., Scarpi, E., Maltoni, M., et al. Impact of palliative care unit admission on symptom control evaluated by the Edmonton Symptom Assessment System. J Pain Symptom Manage 30 (2005), 367–373.
55. 55 Kang, J.H., Kwon, J.H., Hui, D., Yennurajalingam, S., Bruera, E., Changes in symptom intensity among cancer patients receiving outpatient palliative care. J Pain Symptom Manage 46 (2013), 652–660.
56. 56 Yennurajalingam, S., Kang, J.H., Hui, D., Kang, D.H., Kim, S.H., Bruera, E., Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain. J Pain Symptom Manage 44 (2012), 340–350.
57. 57 Kim, Y., Yen, I.H., Rabow, M.W., Comparing symptom burden in patients with metastatic and nonmetastatic cancer. J Palliat Med 19 (2016), 64–68.
58. 58 Paiva, C.E., Faria, C.B., Nascimento, M.S., et al. Effectiveness of a palliative care outpatient programme in improving cancer-related symptoms among ambulatory Brazilian patients. Eur J Cancer Care (Engl) 21 (2012), 124–130.
59. 59 Thomas, S., Walsh, D., Shrotriya, S., et al. Symptoms, quality of life, and daily activities in people with newly diagnosed solid tumors presenting to a medical oncologist. Am J Hosp Palliat Care, 2016 (in press).
60. 60 Barbera, L., Seow, H., Howell, D., et al. Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer 116 (2010), 5767–5776.
61. 61 Bradley, N., Davis, L., Chow, E., Symptom distress in patients attending an outpatient palliative radiotherapy clinic. J Pain Symptom Manage 30 (2005), 123–131.
62. 62 Aigner, C.J., Hernandez, M., Koyyalagunta, L., Novy, D., The association of presurgery psychological symptoms with postsurgery pain among cancer patients receiving implantable devices for pain management. Support Care Cancer 22 (2014), 2323–2328.
63. 63 Chu, L., Hawley, P., Munk, P., Mallinson, P., Clarkson, P., Minimally invasive palliative procedures in oncology: a review of a multidisciplinary collaboration. Support Care Cancer 23 (2015), 1589–1596.
64. 64 Lefkowits, C., W Rabow, M., E Sherman, A., et al. Predictors of high symptom burden in gynecologic oncology outpatients: who should be referred to outpatient palliative care?. Gynecol Oncol 132 (2014), 698–702.
65. 65 Spoozak, L., Seow, H., Liu, Y., Wright, J., Barbera, L., Performance status and symptom scores of women with gynecologic cancer at the end of life. Int J Gynecol Cancer 23 (2013), 971–978.
66. 66 Davison, S.N., Jhangri, G.S., Johnson, J.A., Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transpl 21 (2006), 3189–3195.
67. 67 Flythe, J.E., Powell, J.D., Poulton, C.J., et al. Patient-reported outcome instruments for physical symptoms among patients receiving maintenance dialysis: a systematic review. Am J Kidney Dis 66 (2015), 1033–1046.
68. 68 Shah, A.B., Udeoji, D.U., Baraghoush, A., Bharadwaj, P., Yennurajalingam, S., Schwarz, E.R., An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med 16 (2013), 87–90.
69. 69 Udeoji, D.U., Shah, A.B., Bharadwaj, P., Katsiyiannis, P., Schwarz, E.R., Evaluation of the prevalence and severity of pain in patients with stable chronic heart failure. World J Cardiol 4 (2012), 250–255.
70. 70 Walke, L.M., Gallo, W.T., Tinetti, M.E., Fried, T.R., The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med 164 (2004), 2321–2324.
71. 71 Poonja, Z., Brisebois, A., van Zanten, S.V., Tandon, P., Meeberg, G., Karvellas, C.J., Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol 12 (2014), 692–698.
72. 72 Lopez, G., Liles, D.K., Knupp, C.L., Edmonton Symptom Assessment System for outpatient symptom monitoring of sickle cell disease. South Med J 107 (2014), 768–772.
73. 73 Dudgeon, D.J., Knott, C., Eichholz, M., et al. Palliative Care Integration Project (PCIP) quality improvement strategy evaluation. J Pain Symptom Manage 35 (2008), 573–582.
74. 74 Dudgeon, D., King, S., Howell, D., et al. Cancer Care Ontario's experience with implementation of routine physical and psychological symptom distress screening. Psychooncology 21 (2012), 357–364.
75. 75 Pereira, J., Green, E., Molloy, S., et al. Population-based standardized symptom screening: cancer care Ontario's Edmonton Symptom Assessment System and performance status initiatives. J Oncol Pract/Am Soc Clin Oncol 10 (2014), 212–214.
76. 76 Pereira, J.L., Chasen, M.R., Molloy, S., et al. Cancer care professionals' attitudes toward systematic standardized symptom assessment and the Edmonton Symptom Assessment System after large-scale population-based implementation in Ontario, Canada. J Pain Symptom Manage 51 (2016), 662–672.e668.
77. 77 Hui, D., Masanori, M., Watanabe, S., et al. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol 17 (2016), e552–e559.
78. 78 Chasen, M., Bhargava, R., Dalzell, C., Pereira, J.L., Attitudes of oncologists towards palliative care and the Edmonton Symptom Assessment System (ESAS) at an Ontario cancer center in Canada. Support Care Cancer 23 (2015), 769–778.
79. 79 Shamieh, O., Khamash, O., Khraisat, M., et al. Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan. Support Care Cancer 25 (2016), 177–183.
80. 80 Cummings, G., Biondo, P.D., Campbell, D., et al. Can the global uptake of palliative care innovations be improved? Insights from a bibliometric analysis of the Edmonton Symptom Assessment System. Palliat Med 25 (2011), 71–82.
81. 81 Seow, H., Barbera, L., Sutradhar, R., et al. Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol 29 (2011), 1151–1158.
82. 82 Jia, J., Barbera, L., Sutradhar, R., Using Markov multistate models to examine the progression of symptom severity among an ambulatory population of cancer patients: are certain symptoms better managed than others?. J Pain Symptom Manage 51 (2016), 232–239.
83. 83 Dev, R., Parsons, H.A., Palla, S., Palmer, J.L., Del Fabbro, E., Bruera, E., Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer 117 (2011), 4551–4556.
84. 84 Kim, Y.J., Dev, R., Reddy, A., et al. Association between tobacco use, symptom expression, and alcohol and illicit drug use in advanced cancer patients. J Pain Symptom Manage 51 (2016), 762–768.
85. 85 Hui, D., Kilgore, K., Park, M., Williams, J., Liu, D., Bruera, E., Impact of prophylactic fentanyl pectin nasal spray on exercise-induced episodic dyspnea in cancer patients: a double-blind, randomized controlled trial. J Pain Symptom Manage 52 (2016), 459–468.
86. 86 Chen, E., Nguyen, J., Cramarossa, G., et al. Symptom clusters in patients with advanced cancer: sub-analysis of patients reporting exclusively non-zero ESAS scores. Palliat Med 26 (2012), 826–833.
87. 87 Jimenez, A., Madero, R., Alonso, A., et al. Symptom clusters in advanced cancer. J Pain Symptom Manage 42 (2011), 24–31.
88. 88 Dong, S.T., Butow, P.N., Costa, D.S., Lovell, M.R., Agar, M., Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manage 48 (2014), 411–450.
89. 89 Yu, D.S., Chan, H.Y., Leung, D.Y., Hui, E., Sit, J.W., Symptom clusters and quality of life among patients with advanced heart failure. J Geriatr Cardiol 13 (2016), 408–414.
90. 90 Parsons, H.A., Delgado-Guay, M.O., El Osta, B., et al. Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med 11 (2008), 964–968.
91. 91 Hui, D., de la Cruz, M., Thorney, S., Parsons, H.A., Delgado-Guay, M., Bruera, E., The frequency and correlates of spiritual distress among patients with advanced cancer admitted to an acute palliative care unit. Am J Hosp Palliat Care 28 (2011), 264–270.
92. 92 Delgado-Guay, M., Parsons, H.A., Li, Z., Palmer, J.L., Bruera, E., Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17 (2009), 573–579.
93. 93 Centeno, C., Sanz, A., Cuervo, M.A., et al. Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients. BMJ Support Palliat Care 2 (2012), 328–333.
94. 94 Salas, S., Frasca, M., Planchet-Barraud, B., et al. Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care. J Palliat Med 15 (2012), 287–293.
95. 95 Del Fabbro, E., Dev, R., Hui, D., Palmer, L., Bruera, E., Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol 31 (2013), 1271–1276.
96. 96 Del Fabbro, E., Garcia, J.M., Dev, R., et al. Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial. Support Care Cancer 21 (2013), 2599–2607.
97. 97 Bandieri, E., Romero, M., Ripamonti, C.I., et al. Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol 34 (2016), 436–442.
98. 98 Bruera, E., Moyano, J.R., Sala, R., et al. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage 28 (2004), 381–388.
99. 99 Bruera, E., El Osta, B., Valero, V., et al. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 25 (2007), 3475–3481.
100. 100 Bruera, E., Hui, D., Dalal, S., et al. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31 (2013), 111–118.
101. 101 Follwell, M., Burman, D., Le, L.W., et al. Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. J Clin Oncol 27 (2009), 206–213.
102. 102 Hui, D., Glitza, I., Chisholm, G., Yennu, S., Bruera, E., Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer 119 (2012), 1098–1105.
103. 103 Yennurajalingam, S., Frisbee-Hume, S., Palmer, J.L., et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31 (2013), 3076–3082.
104. 104 Hui, D., Kilgore, K., Frisbee-Hume, S., et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. J Pain Symptom Manage 52 (2016), 8–16.
105. 105 Zimmermann, C., Swami, N., Krzyzanowska, M., et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383 (2014), 1721–1730.
106. 106 Bakitas, M., Lyons, K.D., Hegel, M.T., et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302 (2009), 741–749.
107. 107 Carli Buttenschoen, D., Stephan, J., Watanabe, S., Nekolaichuk, C., Health care providers' use and knowledge of the Edmonton Symptom Assessment System (ESAS): is there a need to improve information and training?. Support Care Cancer 22 (2014), 201–208.
108. 108 Hui, D., Mori, M., Parsons, H., et al. The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage 43 (2012), 582–592.
109. 109 Hui, D., De La Cruz, M., Mori, M., et al. Concepts and definitions for “supportive care,” “best supportive care,” “palliative care,” and “hospice care” in the published literature, dictionaries, and textbooks. Support Care Cancer 21 (2013), 659–685.
110. 110 Hui, D., Nooruddin, Z., Didwaniya, N., et al. Concepts and definitions for “actively dying,” “end of life,” “terminally ill,” “terminal care,” and “transition of care”: a systematic review. J Pain Symptom Manage 47 (2014), 77–89.
111. 111 Bush, S.H., Parsons, H.A., Palmer, J.L., Li, Z., Chacko, R., Bruera, E., Single- vs. multiple-item instruments in the assessment of quality of life in patients with advanced cancer. J Pain Symptom Manage 39 (2010), 564–571.
112. 112 Lien, K., Zeng, L., Zhang, L., et al. Predictive factors for well-being in advanced cancer patients referred for palliative radiotherapy. Clin Oncol (R Coll Radiol 24 (2012), 443–451.
113. 113 Harrison, L.D., Zhang-Salomons, J., Mates, M., Booth, C.M., King, W.D., Mackillop, W.J., Comparing effectiveness with efficacy: outcomes of palliative chemotherapy for non-small-cell lung cancer in routine practice. Curr Oncol (Toronto, Ont) 22 (2015), 184–191.
114. 114 Schick-Makaroff, K., Molzahn, A., Strategies to use tablet computers for collection of electronic patient-reported outcomes. Health Qual Life Outcomes, 13, 2015, 2.
115. 115 Kallen, M.A., Yang, D., Haas, N., A technical solution to improving palliative and hospice care. Support Care Cancer 20 (2012), 167–174.
116. 116 Strasser, F., Blum, D., von Moos, R., et al. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Ann Oncol 27 (2016), 324–332.
117. 117 Wagner, L.I., Schink, J., Bass, M., et al. Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care. Cancer 121 (2015), 927–934.
118. 118 Nguyen, J., Di Giovanni, J., Zhang, L., et al. Projected referral to other healthcare services in an outpatient palliative radiotherapy clinic. Expert Rev Pharmacoecon Outcomes Res 12 (2012), 237–243.
119. 119 Pirl, W.F., Fann, J.R., Greer, J.A., et al. Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer 120 (2014), 2946–2954.
120. 120 Watanabe, S.M., Nekolaichuk, C.L., Beaumont, C., The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement. Psychooncology 21 (2012), 977–985.
121. 121 Hui, D., Meng, Y.C., Bruera, S., et al. Referral criteria for outpatient palliative cancer care: a systematic review. Oncologist 21 (2016), 895–901.
122. 122 Strasser, F., Sweeney, C., Willey, J., Benisch-Tolley, S., Palmer, J.L., Bruera, E., Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manag 27 (2004), 481–491.
123. 123 Riechelmann, R.P., Krzyzanowska, M.K., O'Carroll, A., Zimmermann, C., Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 15 (2007), 1407–1412.
124. 124 Wentlandt, K., Krzyzanowska, M.K., Swami, N., Rodin, G.M., Le, L.W., Zimmermann, C., Referral practices of oncologists to specialized palliative care. J Clin Oncol 30 (2012), 4380–4386.
125. 125 Watanabe, S.M., Fairchild, A., Pituskin, E., Borgersen, P., Hanson, J., Fassbender, K., Improving access to specialist multidisciplinary palliative care consultation for rural cancer patients by videoconferencing: report of a pilot project. Support Care Cancer 21 (2013), 1201–1207.
126. 126 Wentlandt, K., Krzyzanowska, M.K., Swami, N., et al. Referral practices of pediatric oncologists to specialized palliative care. Support Care Cancer 22 (2014), 2315–2322.
127. 127 Schenker, Y., Crowley-Matoka, M., Dohan, D., et al. Oncologist factors that influence referrals to subspecialty palliative care clinics. J Oncol Pract 10 (2013), e37–e44.
128. 128 Hui, D., Bruera, E., Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol 13 (2016), 159–171.
129. 129 Dhiliwal, S., Salins, N., Deodhar, J., Rao, R., Muckaden, M.A., Pilot testing of triage coding system in home-based palliative care using Edmonton Symptom Assessment Scale. Indian J Palliat Care 22 (2016), 19–24.
130. 130 Dalal, S., Hui, D., Nguyen, L., et al. Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 118 (2012), 3869–3877.